Nimbex (AbbVie Inc.)
Welcome to the PulseAid listing for the Nimbex drug offered from AbbVie Inc.. This Neuromuscular Nondepolarizing Blockade [PE],Nondepolarizing Neuromuscular Blocker [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | AbbVie Inc. |
| NON-PROPRIETARY NAME: | Cisatracurium besylate |
| SUBSTANCE NAME: | CISATRACURIUM BESYLATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Neuromuscular Nondepolarizing Blockade [PE],Nondepolarizing Neuromuscular Blocker [EPC] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2010-12-09 |
| END MARKETING DATE: | 0000-00-00 |
Nimbex HUMAN PRESCRIPTION DRUG Details:
| Item Description | Nimbex from AbbVie Inc. |
| LABELER NAME: | AbbVie Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 2(mg/mL) |
| START MARKETING DATE: | 2010-12-09 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0074-4378_1d2b02aa-595a-6465-8b17-4ab046b0fe2a |
| PRODUCT NDC: | 0074-4378 |
| APPLICATION NUMBER: | NDA020551 |
Other CISATRACURIUM BESYLATE Pharmaceutical Manufacturers / Labelers:
